Minimally Invasive Pancreatoduodenectomy: Contemporary Practice, Evidence, and Knowledge Gaps Jacob GhotbiMushegh SahakyanDyre Kleive Commentary Open access 12 July 2022 Pages: 301 - 315
Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management Piyu Parth NaikMunaf B. Desai Review Open access 21 June 2022 Pages: 317 - 335
The Implementation of Minimally Invasive Surgery in the Treatment of Esophageal Cancer: A Step Toward Better Outcomes? Tania TriantafyllouPieter van der SluisBas P. L. Wijnhoven Review Open access 10 August 2022 Pages: 337 - 349
Pegfilgrastim Biosimilars in US Supportive Oncology: A Narrative Review of Administration Options and Economic Considerations to Maximize Patient Benefit Sophia Z. HumphreysRobert B. GellerPaul Walden Review Open access 16 September 2022 Pages: 351 - 361
The Anticancer Effect of Metformin Combined with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with or Without Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis Qiman ZhangJin ZhengFei-Long Wei Review Open access 25 October 2022 Pages: 363 - 375
The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines Atiye Saeedi SadrHassan EhteramHamed Haddad Kashani Original Research Open access 25 April 2022 Pages: 377 - 388
Correction to: The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines Atiye Saeedi SadrHassan EhteramHamed Haddad Kashani Correction Open access 12 May 2022 Pages: 389 - 389
Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT) Jason T. HurwitzShannon VaffisSuzanne Parry Original Research Open access 13 May 2022 Pages: 391 - 409
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States Sundar JagannathNedra JosephNina Shah Original Research Open access 17 May 2022 Pages: 411 - 420
Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making Thomas W. LeBlancNigel H. RussellRoland B. Walter Original Research Open access 13 June 2022 Pages: 421 - 440
Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation Yonaton ZarbivYael Berner WygodaLuna Kadouri Original Research Open access 25 June 2022 Pages: 441 - 450
Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer Hassan EhteramFatemeh AslanbeigiHamed Haddad Kashani Original Research Open access 18 August 2022 Pages: 451 - 461
Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study Scott PaulsonDavid RayEric Liu Original Research Open access 22 September 2022 Pages: 463 - 479
The Role of Electronic Patient-Reported Outcome Measures in Assessing Smoking Status and Cessation for Patients with Lung Cancer James ConvillFiona BlackhallFabio Gomes Original Research Open access 12 October 2022 Pages: 481 - 491
MRI Grading Scale Predicts Ambulatory Function After Radiotherapy for Metastatic Spinal Cord Compression: A Prospective Single-Institution Observational Study Natsuko YanoTakashi OnoKenji Nemoto Brief Report Open access 19 July 2022 Pages: 493 - 501
